Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients.

Arientová S, Matúšková K, Bartoš O, Beran O, Holub M

DOI: 10.3390/jcm13216340
Published: 2024 Oct 23
Container: Journal of clinical medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/jcm13216340,
  title = {Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients.},
  author = {Arientová S and Matúšková K and Bartoš O and Beran O and Holub M},
  year = {2024},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm13216340},
  url = {https://doi.org/10.3390/jcm13216340}
}

RIS

TY  - JOUR
TI  - Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients.
AU  - Arientová S
AU  - Matúšková K
AU  - Bartoš O
AU  - Beran O
AU  - Holub M
PY  - 2024
JO  - Journal of clinical medicine
DO  - 10.3390/jcm13216340
UR  - https://doi.org/10.3390/jcm13216340
ER  -

APA

S, A., K, M., O, B., O, B., & M, H. (2024). Evaluation of Soluble Urokinase Plasminogen Activator Receptor in COVID-19 Patients.. Journal of clinical medicine. https://doi.org/10.3390/jcm13216340

Source records

pubmed · retrieved 2026-09-24T23:47:59.551Z